Stability of mRNA influences steoporotic bone mass via CNOT3
Stability of mRNA influences steoporotic bone mass via CNOT3
复制标题
mRNA 的稳定性通过 CNOT3 影响骨质疏松骨量
DOI:
10.1073/pnas.1316932111
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
M. Yamamoto T. (13名)
中科院分区:
文献类型:
--
作者:
Watanabe;C. Morita;M. Yamamoto T. (13名)
Osteoclastogenesis is under the control of posttranscriptional and transcriptional events. However, posttranscriptional regulation of osteoclastogenesis is incompletely understood. CNOT3 is a component of the CCR4 family that regulates mRNA stability, but its function in bone is not known. Here, we show thatCnot3deficiency by deletion of a single allele induces osteoporosis.Cnot3deficiency causes an enhancement in bone resorption in association with an elevation in bone formation, resulting in high-turnover type bone loss. At the cellular level,Cnot3deficiency enhances receptor activator of NF-κB ligand (RANKL) effects on osteoclastogenesis in a cell-autonomous manner. Conversely,Cnot3deficiency does not affect osteoblasts directly.Cnot3deficiency does not alter RANKL expression but enhances receptor activator of NF-κB (RANK) mRNA expression in bone in vivo.Cnot3deficiency promotes RANK mRNA stability about twofold in bone marrow cells of mice.Cnot3knockdown also increases RANK mRNA expression in the precursor cell line for osteoclasts. Anti-CNOT3 antibody immunoprecipitates RANK mRNA.Cnot3deficiency stabilizes luciferase reporter expression linked to the 3′-UTR fragment of RANK mRNA. In contrast,Cnot3overexpression destabilizes the luciferase reporter linked to RANK 3′-UTR. In aged mice that exhibit severe osteoporosis,Cnot3expression levels in bone are reduced about threefold in vivo. Surprisingly,Cnot3deficiency in these aged mice further exacerbates osteoporosis, which also occurs via enhancement of osteoclastic activity. Our results reveal that CNOT3 is a critical regulator of bone mass acting on bone resorption through posttranscriptional down-regulation of RANK mRNA stability, at least in part, even in aging-induced osteoporosis.